Who Holds Boundless Bio, Inc. (BOLD)? 40 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 40 holders, $37 million in total.
Largest holders
The 40 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| ARCH Venture Management, LLC | 2,694,095 | $7 million | New | 13F |
| FMR LLC | 2,581,055 | $6 million | -4% | 13F |
| TANG CAPITAL MANAGEMENT LLC | 2,559,875 | $6 million | New | 13F |
| ADAR1 Capital Management, LLC | 1,968,216 | $5 million | New | 13F |
| Cormorant Asset Management, LP | 1,000,000 | $3 million | New | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 614,923 | $2 million | +3% | 13F |
| WELLINGTON MANAGEMENT GROUP LLP | 556,233 | $1 million | +0% | 13F |
| MILLENNIUM MANAGEMENT LLC | 478,639 | $1 million | +379% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 471,570 | $1 million | +18% | 13F |
| Alyeska Investment Group, L.P. | 300,000 | $750,000 | +0% | 13F |
| Affinity Asset Advisors, LLC | 250,000 | $625,000 | New | 13F |
| RBF Capital, LLC | 200,000 | $500,000 | +0% | 13F |
| Ensign Peak Advisors, Inc | 159,835 | $399,588 | -15% | 13F |
| Stonepine Capital Management, LLC | 154,595 | $386,488 | -74% | 13F |
| CITADEL ADVISORS LLC | 145,049 | $362,623 | -89% | 13F |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 128,000 | $320,000 | +153% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 116,736 | $291,839 | -8% | 13F |
| BlackRock, Inc. | 88,495 | $221,239 | +25% | 13F |
| PRELUDE CAPITAL MANAGEMENT, LLC | 83,998 | $209,995 | New | 13F |
| Rangeley Capital, LLC | 74,000 | $185,000 | New | 13F |
| VANGUARD FIDUCIARY TRUST CO | 65,136 | $162,840 | +0% | 13F |
| JANE STREET GROUP, LLC | 64,323 | $160,807 | New | 13F |
| SUPERSTRING CAPITAL MANAGEMENT LP | 55,356 | $138,390 | New | 13F |
| NORTHERN TRUST CORP | 34,824 | $87,060 | New | 13F |
| XTX Topco Ltd | 33,361 | $83,403 | -4% | 13F |
| Qube Research & Technologies Ltd | 20,207 | $50,518 | +16% | 13F |
| China Universal Asset Management Co., Ltd. | 16,900 | $42,250 | New | 13F |
| STATE STREET CORP | 15,962 | $39,905 | +0% | 13F |
| MORGAN STANLEY | 13,000 | $32,500 | +0% | 13F |
| Caitong International Asset Management Co., Ltd | 10,443 | $26,108 | +348000% | 13F |
| Pure Financial Advisors, LLC | 10,100 | $25,250 | +0% | 13F |
| Tower Research Capital LLC (TRC) | 348 | $870 | -85% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 176 | $440 | -1% | 13F |
| JPMORGAN CHASE & CO | 179 | $439 | +6% | 13F |
| ACADIAN ASSET MANAGEMENT LLC | 146,757 | $365 | +1064% | 13F |
| HRT FINANCIAL LP | 116,288 | $290 | New | 13F |
| GSA CAPITAL PARTNERS LLP | 72,353 | $181 | -25% | 13F |
| SBI Securities Co., Ltd. | 2 | $5 | +100% | 13F |
| Financial Management Professionals, Inc. | 2 | $5 | New | 13F |
| UBS Group AG | 2 | $5 | +0% | 13F |
Questions and answers
- How many institutions hold Boundless Bio, Inc.?
- 40 managers reported Boundless Bio, Inc. on Form 13F for the quarter ended 30 June 2026, against 36 the quarter before.
- Who is the largest institutional holder of Boundless Bio, Inc.?
- ARCH Venture Management, LLC, with 2,694,095 shares worth $7 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Boundless Bio, Inc. in Q2 2026?
- 13 managers reported a new position and 9 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Boundless Bio, Inc., Q2 2026", https://app.tamarly.ai/holders/boundless-bio, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.